ESMO Consensus Guidelines: Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy

Published in 2011 - Ann Oncol (2011) 22 (7): 1507-1519.
Authors: E. Felip, C. Gridelli, P. Baas, R. Rosell, R. Stahel

The consensus agreement on these areas: NSCLC pathology and molecular testing, the treatment of first-line, and second-line/third-line therapy in metastatic NSCLC are reported in this article.

Download the PDF from Annals of Oncology